Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/18/2865089/0/en/BioSenic-S-A-Transparency-notifications-received-from-Fran%C3%A7ois-Rieger.html
https://www.globenewswire.com/news-release/2024/04/12/2862067/0/en/BioSenic-provides-further-information-on-its-restructuring-plan.html
https://www.globenewswire.com/news-release/2024/04/11/2861463/0/en/BioSenic-and-its-restructuring-practitioner-Me-Yves-Brulard-submit-a-global-restructuring-plan-covering-the-years-2024-2030-to-the-Enterprise-Court-of-Nivelles.html
https://www.globenewswire.com/news-release/2024/03/29/2854621/0/en/BioSenic-S-A-Information-on-the-total-number-of-voting-rights-and-shares.html
https://www.globenewswire.com/news-release/2024/03/20/2849084/0/en/BioSenic-presents-successful-preclinical-data-on-its-ATO-medication-for-controlling-key-symptoms-at-the-2024-Systemic-Sclerosis-World-Congress.html
https://www.globenewswire.com//news-release/2024/03/12/2844275/0/en/BioSenic-releases-details-of-optimized-administration-approach-ahead-of-planned-Phase-3-trial-of-OATO-for-chronic-graft-versus-host-disease.html
https://www.globenewswire.com//news-release/2024/02/29/2837590/0/en/BioSenic-S-A-Information-on-the-total-number-of-voting-rights-and-shares.html
https://www.globenewswire.com//news-release/2024/02/02/2822980/0/en/BioSenic-raises-500-000-in-private-placement-of-new-shares-with-established-new-investors.html
https://www.globenewswire.com/news-release/2024/01/31/2820799/0/en/BioSenic-provides-support-to-forthcoming-European-conference-on-graft-versus-host-disease.html
https://www.globenewswire.com/news-release/2024/01/30/2819580/0/en/BioSenic-patent-granted-in-Canada-for-broader-protection-of-ATO-therapeutic-platform.html